top of page
belkaid_yasmine-18.jpg

Pasteur 2030 Strategy

The Pasteur 2030 stratgic vision propels the Institut Pasteur into the future by addressing the most critical health challenges of our time.  Focused on innovation, multidisciplinary research and global collaboration, Pasteur 2030 aims to strengthen our scientific leadership while enhancing public health impact. 

Pasteur 2030

Strengthening it's role as the world's leading institute in research on living organisms, against infectious disease and for population health, the Institut Pasteur has developed an ambitious strategic plan for 2030 to meet the major scientific and health challenges of the coming years. 

​

Under the leadership of Professor Yasmine Belkaid, Director General, and in coordination with all its collaborators, the Pasteur 2030 strategy seeks to advance our understanding of diseases, find solutions to combat them and share knowledge while defending the values of science.

​

Faced with the many risks to human health, such as infectious diseases, antibiotic resistance, aging, climate change, chronic inflammatory diseases, cancers which increasingly affect young people, and neurodegenerative diseases, the Institut Pasteur wishes to strengthen its role as the world's leading research organisation in understanding and combating these diseases by 2030.

Four Focus Areas

The four main focus areas of the Pasteur 2030 strategy are:

Pillar 1: Environmental Transitions and Health

Adapting to a Changing World

The health impacts of climate change and environmental degradation are becoming increasingly apparent. Rising temperatures, habitat disruption, and changing ecosystems create new opportunities for pathogens to thrive, leading to the emergence and re-emergence of infectious diseases. The Institut Pasteur is uniquely positioned to address these challenges through its multidisciplinary approach.

Key Focus Areas

VECTOR-BORNE DISEASES

Researching mosquito- and tick-borne illnesses such as malaria, dengue, Zika, and Lyme disease, with the aim of predicting outbreaks and developing effective interventions.

EMERGING PATHOGENS
 

Studying pathogens that arise due to environmental shifts, including their modes of transmission and potential for pandemics.

ENVIRONMENTAL MONITORING
 

Utilizing cutting-edge technologies, including satellite data and artificial intelligence, to map and predict disease hotspots linked to environmental changes.

ONE HEALTH APPROACH
 

Integrating the study of human, animal, and environmental health to create holistic prevention and treatment strategies.

Innovations in Progress

Development of biosensors to detect pathogen presence in ecosystems.

Creation of predictive models for climate-sensitive diseases.

Collaborative initiatives with the Pasteur Network to strengthen surveillance in high-risk regions

Pasteur-UK Projects 

Tracking and Treating Malaria

LSHTM square_edited.png

Tackling Neglected Tropical Diseases

Pillar 2: Infectious Disease Threats

Strengthening Defenses Against Persistent and Emerging Threats 

The world remains vulnerable to infectious diseases, from long-standing challenges like tuberculosis to emerging threats such as SARS-CoV-2. The Institut Pasteur is leveraging its historical leadership in microbiology and infectious diseases to combat these risks and address the growing challenge of antimicrobial resistance (AMR).

Key Focus Areas

ANTIMICROBIAL RESISTANCE
 

Tackling the 'silent pandemic' of AMR through new drug discovery, stewardship programs, and global surveillance initiatives 

INNOVATIVE VACCINES
 

Advancing vaccine development for known and emerging pathogens, such as COVID-19 variants, Ebola, and influenza.

RAPID DIAGNOSTICS
 

Developing fast, affordable diagnostic tools to identify pathogens and AMR strains.

GLOBAL PREPAREDNESS
 

Stengthening systems to detect and respond to pandemics in collaboration with global health organisations such as WHO and the Pasteur Network.

Innovations in Progress

Research on novel antibiotics derived from natural compounds.

A global database of AMR genes to track resistance patterns.

Trials of next-generation mRNA vaccines for respiratory and vector-borne diseases.

Pasteur-UK Projects 

Drug Discovery

Diagnostics and Surveillance

Pillar 3: Origins of Disease 

Understanding the Roots of Human Health and Illness

Why do certain individuals develop chronic diseases, while others remain resilient? How do environmental, genetic, and microbial factors intersect to drive the onset of conditions like diabetes, cancer, or inflammatory disorders? The Institut Pasteur is uncovering the answers to these questions by studying the complex mechanisms that underlie human health.

Key Focus Areas

CHRONIC INFLAMMATORY DISORDERS

Investigating the rise of autoimmune diseases and how inflammation contributes to cancer, cardiovascular disease, and more.

THE MICROBIOME'S ROLE
 

Exploring how the trillions of microbes that live in and on our bodies influence disease development, immune function, and mental health.

HOST_PATHOGEN INTERACTIONS
 

Studying how genetic and environmental factors shape individual responses to infections, contributing to long-term outcomes.

UNDERSTANDING DIVERSITY
 

Understanding neurodevelopmental conditions and the support needs required following diagnosis.

Innovations in Progress

Cutting-edge studies into the microbiome's role in regulating immunity and metabolism. 

Advanced imaging to track cellular changes during disease onset.

AI-driven analysis of genetic data to identify markers for disease predisposition. 

Pasteur-UK Projects 

Neurodevelopmental Diversity and Mental Health

Pillar 4: Health and Disease at the Extremes of Life

Protecting the Most Vulnerable

The earliest and latest stages of life are uniquely vulnerable to health challenges. From maternal and child health to aging populations, the Institut Pasteur is committed to advancing science that supports well-being throughout the lifespan.

Key Focus Areas

MATERNAL-CHILD HEALTH

Studying the role of the maternal microbiome during pregnancy and its influence on child development, immunity, and lifelong health.

VACCINATION ACROSS LIFESPANS
 

Developing vaccines tailored for newborns and the elderly, two groups with distinct immune needs.

AGEING AND IMMUNITY
 

Understanding how the immune system changes with age and identifying interventions to reduce susceptibility to infections and chronic diseases.

NEURODEGENERATIVE DISEASE
 

Using novel approaches to better diagnose neurodegenerative diseases early on.

Innovations in Progress

Investigations into the long-term effects of maternal nutrition on child microbiome composition.

Clinical trials for vaccines that are more effective in seniors, focusing on flu, pneumonia and RSV.

Studies on how ageing impacts the efficacy of immunotherapies for cancer.

Pasteur-UK Projects 

Neurodegenerative Diseases and AI

Pasteur Foundation UK is a registered charity in England and Wales (1203634).
Registered address: One Bartholomew Close, London EC1A 7BL

Pasteur Foundation - UK

One Bartholomew Cl, London EC1A 7BL, UK

  • Instagram
  • Facebook
  • LinkedIn
  • YouTube
bottom of page